A Multiple Indicators Multiple Causes (MIMIC) model of Behavioural and Psychological Symptoms in Dementia (BPSD)

Neurobiology of Aging

Volumn 32, Issue 3, 2011, Pages 434-442

  Proitsi, P ^a   Hamilton, G ^a,b   Tsolaki, M ^c   Lupton, M ^a   Daniilidou, M ^c   Hollingworth, P ^d   Archer, N ^a   Foy, C ^a   Stylios, F ^a   McGuinness, B ^e   Todd, S ^e   Lawlor, B ^f   Gill, M ^f   Brayne, C ^g   Rubinsztein, D C ^g   Owen, M ^d   Williams, J ^d   Craig, D ^e   Passmore, P ^e   Lovestone, S ^a   Powell, J F ^a   more..

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^f ST JAMES S HOSPITAL   (Ireland)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Age; Age of onset; Alzheimer's disease (AD); Behavioural sub phenotypes; BPSD; Confirmatory Factor Analysis (CFA); Covariates; Differential Item Functioning (DIF); Disease duration; Factors; Latent variables; MMSE; Multiple Indicators Multiple Causes (MIMIC) model; Neuropsychiatric Inventory (NPI); Structural Equation Modelling (SEM)

Indexed keywords

ADULT; AGE; AGED; AGITATION; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONFIRMATORY FACTOR ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; FACTORIAL ANALYSIS; FEMALE; GREECE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MOOD; MULTIPLE INDICATORS MULTIPLE CAUSES MODELING; NEUROPSYCHIATRIC INVENTORY; ONSET AGE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PSYCHOSIS; SEX DIFFERENCE; STRUCTURAL EQUATION MODELING; UNITED KINGDOM;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DEMENTIA; FACTOR ANALYSIS, STATISTICAL; FEMALE; GREECE; HUMANS; MALE; MENTAL DISORDERS; MENTAL STATUS SCHEDULE; MIDDLE AGED; MODELS, STATISTICAL; PSYCHOMOTOR AGITATION; PSYCHOTIC DISORDERS;

EID: 79952898455     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2009.03.005     Document Type: Article

References (57)

1. Aalten P., de Vugt M.E., Jaspers N., Jolles J., Verhey F.R. The course of neuropsychiatric symptoms in dementia. Part I: findings from the two-year longitudinal Maasbed study. Int. J. Geriatr. Psychiatry 2005, 20:523-530.
2. Aalten P., de Vugt M.E., Jaspers N., Jolles J., Verhey F.R. The course of neuropsychiatric symptoms in dementia. Part II: relationships among behavioural sub-syndromes and the influence of clinical variables. Int. J. Geriatr. Psychiatry 2005, 20:531-536.
3. Aalten P., de Vugt M.E., Lousberg R., Korten E., Jaspers N., Senden B., Jolles J., Verhey F.R. Behavioral problems in dementia: a factor analysis of the neuropsychiatric inventory. Dement. Geriatr. Cogn. Disord. 2003, 15:99-105.
4. Aalten P., Verhey F.R., Boziki M., Bullock R., Byrne E.J., Camus V., Caputo M., Collins D., De Deyn P.P., Elina K., Frisoni G., Girtler N., Holmes C., Hurt C., Marriott A., Mecocci P., Nobili F., Ousset P.J., Reynish E., Salmon E., Tsolaki M., Vellas B., Robert P.H. Neuropsychiatric syndromes in dementia. Results from the European Alzheimer Disease Consortium: part I. Dement. Geriatr. Cogn. Disord. 2007, 24:457-463.
5. Agrawal A., Lynskey M.T. Does gender contribute to heterogeneity in criteria for cannabis abuse and dependence? Results from the national epidemiological survey on alcohol and related conditions. Drug Alcohol Depend. 2007, 88:300-307.
6. Bassiony M.M., Warren A., Rosenblatt A., Baker A., Steinberg M., Steele C.D., Sheppard J.M., Lyketsos C.G. The relationship between delusions and depression in Alzheimer's disease. Int. J. Geriatr. Psychiatry 2002, 17:549-556.
7. Borroni B., Agosti C., Archetti S., Costanzi C., Bonomi S., Ghianda D., Lenzi G.L., Caimi L., Di L.M., Padovani A. Catechol-O-methyltransferase gene polymorphism is associated with risk of psychosis in Alzheimer Disease. Neurosci. Lett. 2004, 370:127-129.
8. Borroni B., Grassi M., Agosti C., Costanzi C., Archetti S., Franzoni S., Caltagirone C., Di L.M., Caimi L., Padovani A. Genetic correlates of behavioral endophenotypes in Alzheimer disease: role of COMT, 5-HTTLPR and APOE polymorphisms. Neurobiol. Aging 2006, 27:1595-1603.
9. Brown T. Confirmatory Factor Analysis for Applied Research 2006, Guildford, New York.
10. Chung M.C., Dennis I., Easthope Y., Werrett J., Farmer S. A multiple-indicator multiple-cause model for posttraumatic stress reactions: personality, coping, and maladjustment. Psychosom. Med. 2005, 67:251-259.
11. Cook S.E., Miyahara S., Bacanu S.A., Perez-Madrinan G., Lopez O.L., Kaufer D.I., Nimgaonkar V.L., Wisniewski S.R., DeKosky S.T., Sweet R.A. Psychotic symptoms in Alzheimer disease: evidence for subtypes. Am. J. Geriatr. Psychiatry 2003, 11:406-413.
12. Craig D., Hart D.J., McCool K., McIlroy S.P., Passmore A.P. The interleukin 1beta gene promoter polymorphism (-511) acts as a risk factor for psychosis in Alzheimer's dementia. Ann. Neurol. 2004, 56:121-124.
13. Craig D., Hart D.J., Passmore A.P. Genetically increased risk of sleep disruption in Alzheimer's disease. Sleep 2006, 29:1003-1007.
14. Craig D., Mirakhur A., Hart D.J., McIlroy S.P., Passmore A.P. A cross-sectional study of neuropsychiatric symptoms in 435 patients with Alzheimer's disease. Am. J. Geriatr. Psychiatry 2005, 13:460-468.
15. Cummings J.L. The Neuropsychiatric Inventory: assessing psychopathology in dementia patients. Neurology 1997, 48:S10-S16.
16. Cummings J.L. Cognitive and behavioral heterogeneity in Alzheimer's disease: seeking the neurobiological basis. Neurobiol. Aging 2000, 21:845-861.
17. Donaldson C., Tarrier N., Burns A. Determinants of carer stress in Alzheimer's disease. Int. J. Geriatr. Psychiatry 1998, 13:248-256.
18. Drevets W.C., Rubin E.H. Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type. Biol. Psychiatry 1989, 25:39-48.
19. Eustace A., Coen R., Walsh C., Cunningham C.J., Walsh J.B., Coakley D., Lawlor B.A. A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease. Int. J. Geriatr. Psychiatry 2002, 17:968-973.
20. Finkel S.I. Research methodologic issues in evaluating behavioral disturbances of dementia. Int. Psychogeriatr. 1996, 8(Suppl. 2):149-150.
21. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state" A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
22. Frisoni G.B., Rozzini L., Gozzetti A., Binetti G., Zanetti O., Bianchetti A., Trabucchi M., Cummings J.L. Behavioral syndromes in Alzheimer's disease: description and correlates. Dement. Geriatr. Cogn. Disord. 1999, 10:130-138.
23. Fuh J.L., Liu C.K., Mega M.S., Wang S.J., Cummings J.L. Behavioral disorders and caregivers' reaction in Taiwanese patients with Alzheimer's disease. Int. Psychogeriatr. 2001, 13:121-128.
24. Gallo J.J., Anthony J.C., Muthen B.O. Age differences in the symptoms of depression: a latent trait analysis. J. Gerontol. 1994, 49:251-264.
25. Gauthier S., Wirth Y., Mobius H.J. Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies. Int. J. Geriatr. Psychiatry 2005, 20:459-464.
26. Gomez R., Vance A. Parent ratings of ADHD symptoms: differential symptom functioning across Malaysian malay and Chinese children. J. Abnorm. Child Psychol. 2008, 36:955-967.
27. Harwood D.G., Ownby R.L., Barker W.W., Duara R. The behavioral pathology in Alzheimer's Disease Scale (BEHAVE-AD): factor structure among community-dwelling Alzheimer's disease patients. Int. J. Geriatr. Psychiatry 1998, 13:793-800.
28. Herrmann N., Rabheru K., Wang J., Binder C. Galantamine treatment of problematic behavior in Alzheimer disease: post-hoc analysis of pooled data from three large trials. Am. J. Geriatr. Psychiatry 2005, 13:527-534.
29. Hollingworth P., Hamshere M.L., Moskvina V., Dowzell K., Moore P.J., Foy C., Archer N., Lynch A., Lovestone S., Brayne C., Rubinsztein D.C., Lawlor B., Gill M., Owen M.J., Williams J. Four components describe behavioral symptoms in 1,120 individuals with late-onset Alzheimer's disease. J. Am. Geriatr. Soc. 2006, 54:1348-1354.
30. Holmes C., Arranz M.J., Powell J.F., Collier D.A., Lovestone S. 5-HT2A and 5-HT2C receptor polymorphisms and psychopathology in late onset Alzheimer's disease. Hum. Mol. Genet. 1998, 7:1507-1509.
31. Holmes C., Smith H., Ganderton R., Arranz M., Collier D., Powell J., Lovestone S. Psychosis and aggression in Alzheimer's disease: the effect of dopamine receptor gene variation. J. Neurol. Neurosurg. Psychiatry 2001, 71:777-779.
32. Hope T., Keene J., Fairburn C., McShane R., Jacoby R. Behaviour changes in dementia. 2: are there behavioural syndromes?. Int. J. Geriatr. Psychiatry 1997, 12:1074-1078.
33. Joreskog, K., Sorbom D. 1996. LISREL 8: User's Reference Guide. Chicago, IL.
34. Lopez O.L., Becker J.T., Sweet R.A., Klunk W., Kaufer D.I., Saxton J., Habeych M., DeKosky S.T. Psychiatric symptoms vary with the severity of dementia in probable Alzheimer's disease. J. Neuropsychiatry Clin. Neurosci. 2003, 15:346-353.
35. Lyketsos C.G., Sheppard J.M., Steinberg M., Tschanz J.A., Norton M.C., Steffens D.C., Breitner J.C. Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. Int. J. Geriatr. Psychiatry 2001, 16:1043-1053.
36. Madhusoodanan S., Shah P., Brenner R., Gupta S. Pharmacological treatment of the psychosis of Alzheimer's disease: what is the best approach?. CNS Drugs 2007, 21:101-115.
37. Mast B.T. Cerebrovascular disease and late-life depression: a latent-variable analysis of depressive symptoms after stroke. Am. J. Geriatr. Psychiatry 2004, 12:315-322.
38. Mast B.T. Impact of cognitive impairment on the phenomenology of geriatric depression. Am. J. Geriatr. Psychiatry 2005, 13:694-700.
39. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
40. Mega M.S., Cummings J.L., Fiorello T., Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology 1996, 46:130-135.
41. Mirakhur A., Craig D., Hart D.J., McLlroy S.P., Passmore A.P. Behavioural and psychological syndromes in Alzheimer's disease. Int. J. Geriatr. Psychiatry 2004, 19:1035-1039.
42. Mizrahi R., Starkstein S.E., Jorge R., Robinson R.G. Phenomenology and clinical correlates of delusions in Alzheimer disease. Am. J. Geriatr. Psychiatry 2006, 14:573-581.
43. Moran M., Walsh C., Lynch A., Coen R.F., Coakley D., Lawlor B.A. Syndromes of behavioural and psychological symptoms in mild Alzheimer's disease. Int. J. Geriatr. Psychiatry 2004, 19:359-364.
44. Muthen l., Muthen B. Mplus User's Guide. Statistical Analysis with Latent Variables 2006, Muthen & Muthen, Los Angeles, CA. 4th ed.
45. Piccininni M., Di C.A., Baldereschi M., Zaccara G., Inzitari D. Behavioral and psychological symptoms in Alzheimer's disease: frequency and relationship with duration and severity of the disease. Dement. Geriatr. Cogn. Disord. 2005, 19:276-281.
46. Rapoport M.J., van R.R., Freedman M., Streiner D., Simard M., Clarke D., Cohen T., Conn D. Relationship of psychosis to aggression, apathy and function in dementia. Int. J. Geriatr. Psychiatry 2001, 16:123-130.
47. Rosen J., Zubenko G.S. Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease. Biol. Psychiatry 1991, 29:224-232.
48. Selbaek G., Kirkevold O., Engedal K. The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. Int. J. Geriatr. Psychiatry 2007, 22:843-849.
49. Senanarong V., Cummings J.L., Fairbanks L., Mega M., Masterman D.M., O'Connor S.M., Strickland T.L. Agitation in Alzheimer's disease is a manifestation of frontal lobe dysfunction. Dement. Geriatr. Cogn. Disord. 2004, 17:14-20.
50. Spalletta G., Baldinetti F., Buccione I., Fadda L., Perri R., Scalmana S., Serra L., Caltagirone C. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease. J. Neurol. 2004, 251:688-695.
51. Steele C., Rovner B., Chase G.A., Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am. J. Psychiatry 1990, 147:1049-1051.
52. Stern Y., Albert M., Brandt J., Jacobs D.M., Tang M.X., Marder K., Bell K., Sano M., Devanand D.P., Bylsma F. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission, and death in Alzheimer's disease: prospective analyses from the Predictors Study. Neurology 1994, 44:2300-2307.
53. Sweet R.A., Devlin B., Pollock B.G., Sukonick D.L., Kastango K.B., Bacanu S.A., Chowdari K.V., DeKosky S.T., Ferrell R.E. Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease. Mol. Psychiatry 2005, 10:1026-1036.
54. Sweet R.A., Nimgaonkar V.L., Kamboh M.I., Lopez O.L., Zhang F., DeKosky S.T. Dopamine receptor genetic variation, psychosis, and aggression in Alzheimer disease. Arch. Neurol. 1998, 55:1335-1340.
55. Sweet R.A., Pollock B.G., Sukonick D.L., Mulsant B.H., Rosen J., Klunk W.E., Kastango K.B., DeKosky S.T., Ferrell R.E. The 5-HTTPR polymorphism confers liability to a combined phenotype of psychotic and aggressive behavior in Alzheimer disease. Int. Psychogeriatr. 2001, 13:401-409.
56. Tariot P.N., Mack J.L., Patterson M.B., Edland S.D., Weiner M.F., Fillenbaum G., Blazina L., Teri L., Rubin E., Mortimer J.A. The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. Am. J. Psychiatry 1995, 152:1349-1357.
57. Wilkosz P.A., Kodavali C., Weamer E.A., Miyahara S., Lopez O.L., Nimgaonkar V.L., DeKosky S.T., Sweet R.A. Prediction of psychosis onset in Alzheimer disease: the role of depression symptom severity and the HTR2A T102C polymorphism. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2007, 144B:1054-1062.